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INTRODUCTION 
Cystic fibrosis is caused by mutations in the 
gene encoding the cystic fibrosis transmembrane 
conductance regulator (CFTR) (Kerem et al., 
1989; Riordan et al., 1989; Rommens et al., 
1989). The clinical manifestations of cystic fibrosis 
are thought to be related to abnormal chloride 
conductance due to defective synthesis, process- 
ing, or function of CFTR chloride channels 
(Welsh, 1990; Drumm et al., 1991; Collins , 1992; 
Welsh et al., 1992; Riordan, 1993). We have iden- 
tified a novel missense mutation in a native-Amer- 
icadcaucasian patient in exon 7 of the C m ,  by 
chemical mismatch cleavage of cDNA obtained 
through reverse transcription of mRNA from nasal 
scraping. 
MATERIALS AND METHODS 
The subject is a 1.3-year-old female. Her ethnic 
background includes DutchErench from the pater- 
nal side and native-American (Cherokee)/Cauca- 
sian from the maternal side. She was diagnosed 
with CF at 3 weeks of age, with a sweat chloride 
concentration of 107 mEq/liter. She is pancreatic 
insufficient. Her height is 142 cm (4% for age) 
and weight is 36 kg (25% for age). Pulmonary 
function testing has revealed FVC of 1.83 liters 
(81% of predicted), and FEVl of 1.47 liters (73% 
of predicted). She recently developed intrahepatic 
biliary cirrhosis and liver failure and is awaiting a 
liver transplant. 
Detection of AF508 Mutation by Reversed Dot- 
Blot Assay was done (Saiki et al., 1989). The pa- 
tient considered here was identified through this 
technique as AF508/unknown. Detection of the 
unknown mutation was done by analysis of CFTR 
mRNA. Nasal epithelial tissue was obtained from 
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the patient and a normal subject by nasal scrape as 
previously described (Strong et al., 1992). RNA 
was extracted from nasal epithelial cells using 
RNAzol B (Tel Test), according to manufacturer's 
specifications. PCR amplification spanning the 
codon region of CFTR cDNA was performed 
through amplification of five overlapping Poly- 
merase Chain Reactions (PCR) using CFTR prim- 
ers (Table 1). The patient was found to be het- 
erozygous for AF508 at the RNA level. Standard 
conditions were used for all PCRs (Sambrook et 
al., 1989) RT/PCR products were visualized in a 
1% agarose gel. Chemical mismatch cleavage 
(CMC) was done as previously described (Strong 
et al., 1991) based on a modification of the pub- 
lished technique (Cotton et al., 1988; Grompe et 
al., 1989). 
The cDNA fragment determined to have a mu- 
tation through the chemical mismatch cleavage 
was amplified, gel purified, and directly sequenced 
based on the method of Kretz et al. (1989) using 
the Sequenase 2.0 Kit (U.S. Biochemical Corp). 
ClTR exon 7 was amplified from genomic DNA 
from the patient, her parents, 25 normal chromo- 
somes, and 25 CF chromosomes by PCR with exon 
7 specific primers: 5 ' AGACCATGCTCAGAT- 
CTTCCAT 3' and 5' GATCAGTTCTAATGA- 
ACT?TGC 3'. The PCR product was digested 
with Ddel and visualized on a 12940 nondenaturing 
polyacrylamide gel. 
The effect of the G3 14R mutation on C1 channel 
function was investigated by expressing the altered 
protein in Xenopus oocytes. The methodology has 
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been described in detail (Drumm et al., 1991; Smit 
et al., 1993). Expression assays were conducted 
under conditions previously shown to give rise to 
robust expression of CFTR-mediated Cl-currents in 
oocytes injected with mRNA transcribed from wild- 
type CFTR or mutants such as AF508. 
RESULTS 
A mismatch was detected in the region of exons 
1-7 (data not shown). The 1130-bp fragment was 
sequenced, and the substitution of C for G was 
detected at 1072 bp. This substitution resulted in 
the change of arginine for glycine at position 314 
(G314R), which, according to the predicted to- 
pology of CFTR, lies in the Sh putative membrane 
spanning segment. The substitution of arginine for 
glycine at 314 results in elimination of a DdeI site. 
Restriction digest analysis revealed that the pa- 
tient is heterozygous for this mutation. To deter- 
mine if this substitution was found in additional 
normal chromosomes or CF chromosomes, DNA 
from our panel of CF parents was amplified and 
restriction analysis was performed. Of 25 normal 
chromosomes and 25 CF chromosomes screened, 
none were identified as having this mutation. The 
purpose of the screening was to detect if this mu- 
tation occurs in high frequency. To our knowledge, 
this mutation has not been identified in other CF 
patients. 
To determine if this mutation is maternal (na- 
tive- American (Cherokee)/Caucasian) or paternal 
(Caucasian) in origin, DNA samples from both 
parents were obtained. Exon 7 of the patient and 
her parents' DNA was amplified and restriction 
digest analysis with DdeI was performed. The 
G314R mutation was identified as maternal (Fig. 
1). The AF508 mutation was shown to be paternal 
(data not shown). It would have been of interest to 
obtain DNA samples from the maternal grandpar- 
ents to track further the ethnic background of the 
mutation; however, both of them are deceased. 
A total of 35 oocytes from 10 different frogs 
were assayed in 10 different rounds of injection 
with G3 14R CFTR. Of these only two exhibited a 
detectable response (80 nA as compared to >800 
nA for wt) to the application of forskolin and 
IBMX. The response of one of these to forskolin 
and IBMX is shown in Figure 2. In contrast, 
oocytes that were injected with mRNA transcribed 
from the wt construct exhibited robust responses to 
the application of 10 pM forskolin and 5 mM 
IBMX. Because the results with G314R were 
largely negative, we also compared CAMP-induced 
C1 currents in oocytes expressing CFTRs in which 
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FIGURE I. Restriction enzyme digestion analysis of exon 7 of 
CFTR of patient and parents. The upper panel shows diges- 
tion of PCR amplified exon 7 with the restriction enzyme 
DdeI generating the expected normal fragments of 255 and 
139 bp. The predicted 15 and 9 bp fragments are not visible 
in this analysis. In the case of the patient (lane 1) and mother 
(lane 2). an additional hagment of 270 bp is present (as is a 
faint heteroduplex), indicating the heterozygous loss of the 
Ddel site at codon 314. The lalwer panel shows a schematic 
representation of the restricti'on enzyme digest analysis of 
exon 7. 
more conservative substitutions were made at the 
same position. CFTR constructs bearing either the 
G3 14A or G3 14E substitution were associated 
with readily discernable CAMP-induced C1 cur- 
rents. The G314E substitution has been associated 
with cystic fibrosis (GollaL et  al., 1994). 
DISCU!SSION 
Cystic fibrosis is characterized by viscous secre- 
tions in the tracheobronchial tree and pancreas 
leading to chronic pulmonary diseases and pancre- 
atic insufficiency in most cases. Diagnosis is made 
by abnormal sweat electrolytes in most cases (Boat 
e t  al., 1989). 
In this report we describe a patient with a nu- 
cleotide substitution in exon 7 in one CFTR allele 
and AF508 in the other allele. This mutation was 
not found in 25 normal c.hromosomes and 25 CF 
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FIGURE 2. Membrane currents recorded from Xenopus oocytes 
at a holding potential of -60 mV. Shown are records from 
oocytes previously injected with mRNA transcribed from 
wild-type (-A-) and G314R (- 0 -1 CFTR along with a record 
from an uninjected oocyte (-O-). In each case, the current following removal of the stimulating cocktail. 
oocyte was exposed to a stimulating cocktail containing 10 
M forskolin and 5 mM IBMX, and the solid line shows the 
time course of activation of CFTR chloride current. The 
dashed lines show the time course for the inactivation of the 





















































chromosomes. The substitution of G to C results in 
a glycine to arginine substitution at amino acid 314 
(G314R). This mutation is in the fifth putative 
hydrophobic transmembrane segment and results 
in the addition of a positive charge and a bulky side 
chain. The mutation is associated with severe dis- 
ease and liver failure in our patient. The mutation, 
being maternal in origin, could be specific to the 
Cherokee CF population. 
Expression of CFTR constructs bearing the 
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G341R mutation in Xenopus oocytes provided ev- 
idence that this substitution severely compromises 
the C1 channel function of CFTR. Cyclic AMP- 
activated C1 currents were only barely detectable 
with this construct, whereas wt and AF508 CFTR, 
as well as variants bearing more conservative sub- 
stitutions at the same site (G314A and G314E), 
were associated with the expression of significant 
C1 channel function. 
Reduced expression of CFTR C1 channel func- 
tion for G3 14R could arise in at least two ways that 
are not mutually exclusive. The mutation could 
result in defective processing of the protein so that 
the amount of CFTR reaching the plasma mem- 
brane is reduced (Cheng et  al., 1990). The muta- 
tion could also compromise the channel function by 
altering either the conduction and/or the gating 
properties of the CFTR C1 channels (Drumm et  al., 
1991; Sheppard et al., 1993). The data presented 
here do not distinguish between these alternatives, 
but it is noteworthy that AF508 CFTR, which is not 
delivered to the plasma membrane of mammalian 
cells at 37"C, nevertheless gives rise to robust C1 
channel activity in Xenopus oocytes (Drumm et  al., 
1991). 
The location of the mutation in the predicted 
membrane spanning domain and the fact that it 
adds a net positive charge raises the possibility that 
the conduction properties of the channel could be 
compromised as shown previously for other muta- 
tions in this domain (Drumm et al., 1991; Shep- 
pard et  al., 1993). 
Regardless of the mechanism, the combination 
of genetic and functional data presented here 
leaves little doubt that the G314R mutation is the 
cause of near total absence of CFTR C1 function 
and severe clinical disease in this patient. 
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